Login / Signup

Efficacy of teriparatide compared with risedronate on FRAX®-defined major osteoporotic fractures: results of the VERO clinical trial.

Jean-Jacques BodyFernando MarinDavid L KendlerCristiano Augusto Freitas ZerbiniPedro López-RomeroR MörickeEnrique Casado BurgosAstrid Fahrleitner-PammerJ J StepanEric LespessaillesSalvatore MinisolaPiet P M M Geusens
Published in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2020)
ClinicalTrials.gov Identifier: NCT01709110 EudraCT Number: 2012-000123-41.
Keyphrases
  • clinical trial
  • bone mineral density
  • postmenopausal women
  • phase ii
  • body composition
  • open label
  • study protocol
  • double blind
  • randomized controlled trial